Validated organ-on-a-chip data, Delivered as a service

OrganoServices is MIMETAS' standardized contract research offering: you provide the compound, we run the experiments. Studies are conducted on the OrganoPlate® platform using validated, physiologically relevant organ models that are also available as OrganoReady®. You don't need any equipment or protocol development on your end: you receive a structured results report, typically within one week of assay completion, and all data and IP remain exclusively yours.

OrganoServices is designed for teams that want human-relevant preclinical data without the overhead of running organ-on-a-chip technology in-house.

Request a quote

OrganoServices

Not every drug discovery team has the time, expertise, or infrastructure to implement and run organ-on-a-chip technology in-house. With OrganoServices, you don't have to.

Fast turnaround time

Hands-off complex assays

Built on highly standardized OrganoReady® models

Why Choose OrganoServices?

Validated assay

Built on our OrganoReady® models, with demonstrated predictive performance on clinical translatability.

Fast turnaround

Results delivered within approximately one week after assay completion.

Standardized workflow

Robust, reproducible protocols performed by experienced scientists.

No specialized equipment required

Access organ-on-a-chip technology without investing in instruments or training.

Confidential by design

All study data and intellectual property remain exclusively yours.

How It Works

You send your compounds

Ship your compounds to our laboratories together with your study requirements.

We run the study

Our scientists perform the experiment using our standardized and validated OrganoReady®

You receive your results

Receive a structured report— within approximately one week after assay completion.

OrganoServices is ideal if you:

Need actionable data quickly

Do not have organ-on-a-chip capabilities in-house

Do not have the time or resources to run your own assays

Need additional human-relevant evidence before advancing a candidate

Prefer outsourcing standardized studies while maintaining full ownership of your data

Standardized Service,
Custom Service, or Product?

OrganoServices

We run the validated assay for you. Results report within one week of assay completion. Your IP, exclusively.

See service

CRO Services

Need a modified protocol, additional endpoints, or a disease-specific model? We design the study with you.

Get in touch

OrganoReady®

Ready-to-use organ models for in-house tox assays on the OrganoPlate®. Full protocols included.

See product

Frequently Asked Questions

How long does a study take?

Typically, results are delivered within approximately one week after assay completion.

Do I need to give input on study design?

No. All experiments are designed and performed by MIMETAS scientists.

Who owns the data?

All generated data and intellectual property remain exclusively yours.

Can the assay be customized?

Yes. If your project requires different endpoints, protocols, or study designs, our CRO Services team can support you.

What endpoints are currently available?

OrganoServices currently supports GI toxicity (viability, barrier integrity) and DIVI (Drug-Induced Vascular Injury; viability, barrier integrity). GI toxicity is built on our clinically benchmarked OrganoReady® Colon Organoid model, validated against 28 reference compounds with known clinical GI toxicity profiles.